Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Amble vs AMP Health

Amble
Graded #221

Lower grade

vs+0.5999999999999943
AMP Health
Graded #202

Higher grade

The verdict

AMP Health takes it — 66.1/100 to 65.5/100, but only just.

AMP Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AMP Health offers compounded semaglutide (injectable and oral) from $199/mo and tirzepatide from $309/mo, plus a $79/mo subscription fee. Amble is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
60
60
Dose & formulationAMP Health +24
64
88
Clinical oversightAmble +4
79
75
Labs & monitoringEven
52
52
FulfillmentAmble +19
81
62
Contract termsAmble +14
55
41
Amble · left barAMP Health · right bar

The numbers

MetricAmbleAMP Health
WeighScore65.5/10066.1/100
GradeCC
Scorecard rank#221#202
Semaglutide$179/mo (starting dose, compounded)$199/mo (compounded)
Tirzepatide$289/mo (starting dose, compounded)$309/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Amble

Graded #221 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
AMP Health

Graded #202 · C

Strengths

  • Semaglutide in both injectable and oral formats
  • Tirzepatide available
  • 30-day satisfaction guarantee
  • Personal nutrition plan and health coaching included

Where it loses points

  • $79/mo subscription fee on top of medication ($278–$388/mo total)
  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • States served not disclosed
  • Brand Wegovy listed but out of stock

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard